Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000892016> ?p ?o ?g. }
- W3000892016 endingPage "108963" @default.
- W3000892016 startingPage "108963" @default.
- W3000892016 abstract "Epigenetic variations can play remarkable roles in different normal and abnormal situations. Such variations have been shown to have a direct role in the pathogenesis of various diseases either through inhibition of tumor suppressor genes or increasing the expression of oncogenes. Enzymes involving in epigenetic machinery are the main actors in tuning the epigenetic-based controls on gene expressions. Aberrant expression of these enzymes can trigger big chaos in the cellular gene expression networks and finally lead to cancer progression. This situation has been shown in different types of leukemia, where high or low levels of an epigenetic enzyme are partly or highly responsible for the involvement or progression of a disease. DNA hypermethylation, different histone modifications, and aberrant miRNA expressions are three main epigenetic variations, which have been shown to play a role in leukemia progression. Epigenetic based treatments now are considered as novel and effective therapies in order to decrease the abnormal epigenetic modifications in patient cells. Different epigenetic-based approaches have been developed and tested to inhibit or reverse the unusual expression of epigenetic agents in leukemia. Acute myeloid leukemia (AML), the most prevalent acute leukemia in adults, is anaggressive hematological malignancy arising in hematopoietic stem and progenitor cells. With the exception of a few specific AML subtypes, the mainstays of treatment have not significantly changed over the last 20 years, and are still based on standard cytotoxic chemotherapy. In this review, we will discuss the recent development of therapeutics specifically targeting these key epigenetic programs in AML, describe their mechanism of action and present their current clinical development. Finally, we will discuss the opportunities presented by epigenetically targeted therapy in AML and will highlight future challenges ahead for the AML community, to ensure that this novel therapeutics are optimally translated into clinical practice and result in clinical improvement for AML patients." @default.
- W3000892016 created "2020-01-30" @default.
- W3000892016 creator A5016048028 @default.
- W3000892016 creator A5024888976 @default.
- W3000892016 creator A5054855160 @default.
- W3000892016 creator A5056099688 @default.
- W3000892016 creator A5064803348 @default.
- W3000892016 creator A5089240018 @default.
- W3000892016 date "2020-02-01" @default.
- W3000892016 modified "2023-10-17" @default.
- W3000892016 title "Role of epigenetic in leukemia: From mechanism to therapy" @default.
- W3000892016 cites W1976988035 @default.
- W3000892016 cites W1980159430 @default.
- W3000892016 cites W1997103981 @default.
- W3000892016 cites W2012550132 @default.
- W3000892016 cites W2041220232 @default.
- W3000892016 cites W2069737223 @default.
- W3000892016 cites W2558026802 @default.
- W3000892016 cites W2593264896 @default.
- W3000892016 cites W2802355956 @default.
- W3000892016 cites W2806273099 @default.
- W3000892016 cites W2809263410 @default.
- W3000892016 cites W2809503521 @default.
- W3000892016 cites W2809914254 @default.
- W3000892016 cites W2810235330 @default.
- W3000892016 cites W2810236764 @default.
- W3000892016 cites W2810532537 @default.
- W3000892016 cites W2883462188 @default.
- W3000892016 cites W2883705282 @default.
- W3000892016 cites W2883977121 @default.
- W3000892016 cites W2884610550 @default.
- W3000892016 cites W2884966116 @default.
- W3000892016 cites W2885150011 @default.
- W3000892016 cites W2885388237 @default.
- W3000892016 cites W2887473761 @default.
- W3000892016 cites W2887554293 @default.
- W3000892016 cites W2887666565 @default.
- W3000892016 cites W2888214283 @default.
- W3000892016 cites W2888356630 @default.
- W3000892016 cites W2889085228 @default.
- W3000892016 cites W2890287079 @default.
- W3000892016 cites W2890529335 @default.
- W3000892016 cites W2890886993 @default.
- W3000892016 cites W2891323954 @default.
- W3000892016 cites W2891391803 @default.
- W3000892016 cites W2891423862 @default.
- W3000892016 cites W2891837607 @default.
- W3000892016 cites W2892042921 @default.
- W3000892016 cites W2892220278 @default.
- W3000892016 cites W2892291303 @default.
- W3000892016 cites W2893367264 @default.
- W3000892016 cites W2894457032 @default.
- W3000892016 cites W2895357719 @default.
- W3000892016 cites W2895463644 @default.
- W3000892016 cites W2895498549 @default.
- W3000892016 cites W2895800080 @default.
- W3000892016 cites W2897051414 @default.
- W3000892016 cites W2897534832 @default.
- W3000892016 cites W2897570538 @default.
- W3000892016 cites W2898278445 @default.
- W3000892016 cites W2898874444 @default.
- W3000892016 cites W2899214619 @default.
- W3000892016 cites W2899542052 @default.
- W3000892016 cites W2899733624 @default.
- W3000892016 cites W2900113259 @default.
- W3000892016 cites W2900644235 @default.
- W3000892016 cites W2900789069 @default.
- W3000892016 cites W2900909304 @default.
- W3000892016 cites W2901151245 @default.
- W3000892016 cites W2901656111 @default.
- W3000892016 cites W2901656766 @default.
- W3000892016 cites W2901949277 @default.
- W3000892016 cites W2902164076 @default.
- W3000892016 cites W2902849275 @default.
- W3000892016 cites W2902963941 @default.
- W3000892016 cites W2903256209 @default.
- W3000892016 cites W2903397329 @default.
- W3000892016 cites W2903648490 @default.
- W3000892016 cites W2904132382 @default.
- W3000892016 cites W2904157469 @default.
- W3000892016 cites W2904176164 @default.
- W3000892016 cites W2904888467 @default.
- W3000892016 cites W2905009573 @default.
- W3000892016 cites W2905661842 @default.
- W3000892016 cites W2906457520 @default.
- W3000892016 cites W2907309697 @default.
- W3000892016 cites W2908176424 @default.
- W3000892016 cites W2909165540 @default.
- W3000892016 cites W2914916650 @default.
- W3000892016 cites W2922258534 @default.
- W3000892016 cites W2960674259 @default.
- W3000892016 cites W2982015028 @default.
- W3000892016 cites W2984339551 @default.
- W3000892016 cites W2891998879 @default.
- W3000892016 doi "https://doi.org/10.1016/j.cbi.2020.108963" @default.
- W3000892016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31978391" @default.
- W3000892016 hasPublicationYear "2020" @default.
- W3000892016 type Work @default.